We are live on
!
Find out more
VOYA Investment Management Portfolio holdings
AUM
$116B
1-Year Est. Return
61.47%
This Fund
S&P 500
This Quarter
Est. Return
+18.35%
1 Year Est. Return
+61.47%
3 Year Est. Return
+172.42%
5 Year Est. Return
+231.94%
10 Year Est. Return
+892.64%
AUM
$49.3B
AUM Growth
+$4.17B
(+9.2%)
Cap. Flow
-$2.67B
Cap. Flow
% of AUM
-5.42%
Top 10 Holdings %
Top 10 Hldgs %
21.05%
Holding
2,729
New
233
Increased
1,401
Reduced
1,043
Closed
48
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$270M |
| 2 |
Qualcomm
QCOM
|
+$245M |
| 3 |
Expedia Group
EXPE
|
+$223M |
| 4 |
DexCom
DXCM
|
+$206M |
| 5 |
Eli Lilly
LLY
|
+$171M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$353M |
| 2 |
AbbVie
ABBV
|
+$340M |
| 3 |
Microsoft
MSFT
|
+$328M |
| 4 |
Cadence Design Systems
CDNS
|
+$280M |
| 5 |
Salesforce
CRM
|
+$252M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.71% |
| 2 | Healthcare | 13.97% |
| 3 | Consumer Discretionary | 13.18% |
| 4 | Financials | 11.29% |
| 5 | Industrials | 8.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2501
Cytosorbents Corp
CTSO
$23.3M
| $141K | ﹤0.01% |
17,679
+4,876
| +38% | +$40.8K |
|
2502
Spyre Therapeutics
SYRE
$9.18B
| $140K | ﹤0.01% |
710
+97
| +16% | +$20.1K |
|
2503
Team
TISI
$101M
| $139K | ﹤0.01% |
1,273
+249
| +24% | +$20.5K |
|
2504
VirnetX Holding Corp
VHC
$65.8M
| $139K | ﹤0.01% |
1,376
+257
| +23% | +$27.8K |
|
|
ATHX
2505
DELISTED
Athersys, Inc. Common Stock
ATHX
| $139K | ﹤0.01% |
3,174
+768
| +32% | +$34.9K |
|
|
CALA
2506
DELISTED
Calithera Biosciences, Inc
CALA
| $138K | ﹤0.01% |
1,400
-1,053
| -43% | -$92.3K |
|
2507
Bridgewater Bancshares
BWB
$614M
| $137K | ﹤0.01% |
+10,969
| New | +$127K |
|
2508
Astronics
ATRO
$4.34B
| $134K | ﹤0.01% |
+12,166
| New | +$99.6K |
|
2509
Old Second Bancorp
OSBC
$1.31B
| $133K | ﹤0.01% |
13,165
+2,819
| +27% | +$26.8K |
|
2510
Caesarstone
CSTE
$104M
| $132K | ﹤0.01% |
+10,223
| New | +$117K |
|
2511
Anavex Life Sciences
AVXL
$316M
| $131K | ﹤0.01% |
24,285
+5,716
| +31% | +$30.1K |
|
2512
TherapeuticsMD
TXMD
$24.1M
| $131K | ﹤0.01% |
2,164
+502
| +30% | +$34.3K |
|
|
LTRPA
2513
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
| $131K | ﹤0.01% |
30,074
+5,058
| +20% | +$13.7K |
|
2514
CytomX Therapeutics
CTMX
$760M
| $128K | ﹤0.01% |
19,604
+4,007
| +26% | +$28.6K |
|
|
MRNS
2515
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $128K | ﹤0.01% |
+10,498
| New | +$146K |
|
2516
Electromed
ELMD
$352M
| $127K | ﹤0.01% |
12,903
+737
| +6% | +$6.94K |
|
2517
Lifecore Biomedical
LFCR
$181M
| $127K | ﹤0.01% |
+11,713
| New | +$121K |
|
|
LITS
2518
Lite Strategy Inc
LITS
$31.4M
| $127K | ﹤0.01% |
2,401
+567
| +31% | +$32.7K |
|
|
PRTK
2519
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $127K | ﹤0.01% |
20,344
+5,861
| +40% | +$34.5K |
|
2520
HF Foods Group
HFFG
$99.2M
| $126K | ﹤0.01% |
16,748
+3,757
| +29% | +$28.4K |
|
|
VXRT
2521
DELISTED
Vaxart
VXRT
| $126K | ﹤0.01% |
22,080
+4,306
| +24% | +$27.4K |
|
2522
Citizens
CIA
$199M
| $125K | ﹤0.01% |
21,732
+3,978
| +22% | +$23.9K |
|
|
EMWP
2523
DELISTED
Eros Media World PLC
EMWP
| $125K | ﹤0.01% |
3,432
+1,037
| +43% | +$45.1K |
|
2524
KALA BIO
KALA
$17.1M
| $124K | ﹤0.01% |
7
+1
| +17% | +$18.8K |
|
2525
Telecom Argentina
TEO
$5.81B
| $123K | ﹤0.01% |
18,756
+2,276
| +14% | +$16.8K |
|
Similar funds
VAM
VOYA Investment Management's Q4 2020 Portfolio in Review
As of Q4 2020, VOYA Investment Management held 2,729 positions worth $49.3B, up 9.2% from $45.2B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
VOYA Investment Management withdrew a net $2.67B in Q4 2020, closing 48 positions and reducing 1,043 holdings. Its most notable exit was Novartis, an estimated $54.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, VOYA Investment Management opened a new position in Concentrix worth $14M.
- VOYA Investment Management's largest Q4 2020 buy was Concentrix: 141,626 shares worth $14M.
- VOYA Investment Management added most to PayPal in Q4 2020, an estimated $270M increase.
- VOYA Investment Management's biggest Q4 2020 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $353M.
- VOYA Investment Management fully exited Novartis in Q4 2020, selling an estimated $54.3M.
- VOYA Investment Management's ten largest holdings make up 21% of its $49.3B portfolio in Q4 2020.
- VOYA Investment Management opened 233 new positions and closed 48 in Q4 2020.
- VOYA Investment Management's portfolio value rose 9.2% quarter-over-quarter to $49.3B.
Based on VOYA Investment Management's 13F filing for Q4 2020, filed 16 Feb 2021.